Cited by 40Mitochondrial Function and PathologyMetabolism and Genetic DisordersBiochemical Acid Research Studies

Bi-allelic mutations of LONP1 encoding the mitochondrial LonP1 protease cause pyruvate dehydrogenase deficiency and profound neurodegeneration with progressive cerebellar atrophy

Open access
Nimmo, Graeme A M, Venkatesh, Sundararajan, Pandey, Ashutosh K, Marshall, Christian R, Hazrati, Lili-Naz, Blaser, Susan, Ahmed, Sohnee, Cameron, Jessie +4 more·2019·Human Molecular Genetics

Abstract

LonP1 is crucial for maintaining mitochondrial proteostasis and mitigating cell stress. We identified a novel homozygous missense LONP1 variant, c.2282 C > T, (p.Pro761Leu), by whole-exome and Sanger sequencing in two siblings born to healthy consanguineous parents. Both siblings presented with stepwise regression during infancy, profound hypotonia and muscle weakness, severe intellectual disability and progressive cerebellar atrophy on brain imaging. Muscle biopsy revealed the absence of ragged-red fibers, however, scattered cytochrome c oxidase-negative staining and electron dense mitochondrial inclusions were observed. Primary cultured fibroblasts from the siblings showed normal levels of mtDNA and mitochondrial transcripts, and normal activities of oxidative phosphorylation complexes I through V. Interestingly, fibroblasts of both siblings showed glucose-repressed oxygen consumption compared to their mother, whereas galactose and palmitic acid utilization were similar. Notably, the siblings' fibroblasts had reduced pyruvate dehydrogenase (PDH) activity and elevated intracellular lactate:pyruvate ratios, whereas plasma ratios were normal. We demonstrated that in the siblings' fibroblasts, PDH dysfunction was caused by increased levels of the phosphorylated E1α subunit of PDH, which inhibits enzyme activity. Blocking E1α phosphorylation activated PDH and reduced intracellular lactate concentrations. In addition, overexpressing wild-type LonP1 in the siblings' fibroblasts down-regulated phosphoE1α. Furthermore, in vitro studies demonstrated that purified LonP1-P761L failed to degrade phosphorylated E1α, in contrast to wild-type LonP1. We propose a novel mechanism whereby homozygous expression of the LonP1-P761L variant leads to PDH deficiency and energy metabolism dysfunction, which promotes severe neurologic impairment and neurodegeneration.

Integrity signals

Registry

Crossref · 10.1093/hmg/ddy351

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Nimmo, G. A. M., Venkatesh, S., Pandey, A. K., Marshall, C. R., Hazrati, L.-N., Blaser, S., Ahmed, S., Cameron, J., Singh, K., Ray, P. N., Suzuki, C. K., & Yoon, G.
Affiliations
  • University of Toronto (CA)
  • Rutgers, The State University of New Jersey (US)
  • Division of Paediatric Neuroradiology, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada
  • Karolinska Institutet (SE)
Corresponding author
  • Suzuki, Carolyn K
  • Yoon, Grace
Venue
Human Molecular Genetics
Published
2018-10-09
Volume
28
Issue
2
Pages
290-306
ISSN
  • 0964-6906 (ISSN-L)
  • 1460-2083
OpenAlex
W2897695914
Cited by
40
References
38
Citations by year
2026: 6 · 2025: 4 · 2024: 5 · 2023: 5 · 2022: 7 · 2021: 4 · 2020: 6 · 2019: 3
FWCI
1.16
Type
journal article
Language
en
Open access
Locations
  • Human Molecular Genetics (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • University of Toronto (MC-2012-13A)
  • National Institutes of Health (1R21HD008391601)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Biochemical Acid Research Studies
Keywords
LONP1, pyruvate dehydrogenase deficiency, mitochondrial proteostasis, neurodegeneration, cerebellar atrophy, missense mutations, consanguinity, mitochondrial dysfunction, lactate/pyruvate ratio, energy metabolism, ragged-red fibers, cytochrome c oxidase
MeSH terms
Alleles, Cerebellar Diseases, DNA, Mitochondrial, Homozygote, Humans, Infant, Newborn, Lactates, Male, Mutation, Pedigree, Phosphorylation, Pyruvate Dehydrogenase Complex Deficiency Disease, Neurodegenerative Diseases, Protein Subunits, Mitochondrial Proteins, ATP-Dependent Proteases, Proteolysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review